Burden of fungal infections in Algeria

Original Article
Part of the following topical collections:
  1. Global Fungal Disease Burden

Abstract

We report for the first time in Algeria and provide burden estimates. We searched for existing data and estimated the incidence and prevalence of fungal diseases based on the population at risk and available epidemiological data. Demographic data were derived from the National Office of Statistics (Office National des Statistiques: ONS), World Health Organization (WHO), The Joint Nations Programme on HIV/AIDS (UNAIDS) and national published reports. When no data existed, risk populations were used to estimate frequencies of fungal infections, using previously described methodology. Algeria has 40.4 million inhabitants, and probably at least 568,900 (1.41%) of Algerians have a serious fungal infection each year. Recurrent vulvovaginal candidiasis (485,000) and fungal asthma (72,000) are probably the commonest problems, as there are over 1 million adult asthmatics. Candidaemia is estimated in 2,020 people, invasive aspergillosis in 2,865 people, and intra-abdominal candidiasis in 303 people; these are the most common life-threatening problems. AIDS is uncommon, but cancer is not (45,000 new cases of cancer including 1,500 in children), nor is COPD (an estimated 317,762 patients, of whom 20.3% are admitted to hospital each year). A focus on improving the diagnosis and epidemiological data related to fungal infection is necessary in Algeria.

References

  1. 1.
    Abid L Organisation actuelle du système national de santé et perspectives.www.sante.dz/colloque/docs/03_organisation_systeme_s_abid.pdf
  2. 2.
    World Health Organization (WHO). http://www.who.int/countries/dza/en/country_profil
  3. 3.
    Zitouni M (2014) Colloque international sur les politiques de santé. http://www.ands.dz/colloque/docs/sante_proximite_rabia.pdf. Accessed 02 Aug 2016
  4. 4.
    Bendjelloul M, Boucherit-Otmania Z, Boucherita K (2016) Study of strains of Candida spp. Isolated from catheters in UHC of Oran (Algeria). Identification and antifungal susceptibility. J Mycol Med 18:S1156–S5233. doi:10.1016/j.mycmed.2016.02.022
  5. 5.
    Arrache D, Madani KH, Achir I, Younsi N, Zebdi A, Bouahri L, Chaouche F, Hamrioui B (2016) Fongémies diagnostiquées au laboratoire de parasitologie-mycologie du CHU Mustapha d’Alger, Algérie (2004—2014). J Mycol Med 237–238. doi:10.1016/j.mycmed.2015.06.049
  6. 6.
    Chekiri M (2013) Aspergillose et Candidose invasive dans deux services à haut risque au CHU -Blida. Doctorat thesis 2013 -Pharmacydepartment -Blida university –ALGERIAGoogle Scholar
  7. 7.
    Arrache D, Zait H, Bouahri L, Bouhellal H, Madani K, Matougui S, Hamiche R, Hamrioui B (2016) Cryptococcose chez les patients non VIH: quatre nouvelles observations sur sarcoïdose, polyarthrite rhumatoïde, cirrhose hépatique et transplantation rénale (2016). J Mycol Med 26, e19. doi:10.1016/j.mycmed.2016.04.043
  8. 8.
    Boucherit-Atmani Z, Seddiki SML, Boucherit K, Sari-Belkharoubi L, Kunke D (2011) Candida albicans biofilms formed into catheters and probes and their resistance to amphotericin B. J Mycol Med 21:182–187. doi:10.1016/j.mycmed.2011.07.006
  9. 9.
    Zait H, Madani K, Abed-Benamara M, Achir I, Hamrioui B (2008) Mycetoma in Algeria about two new cases. Review of cases reported between 1995 and 2005. J Mycol Med 18:116–122. doi:10.1016/j.mycmed.2008.04.001
  10. 10.
    Official demographic data of the Algeria:http://www.ons.dz/img/pdf/demographie2015.pdfGoogle Scholar
  11. 11.
    Zidouni N (2012) La place de la tuberculose dans les deux rives de la méditerranée : 8Th Thoracic Diseases Mediterranean Congress & 21 The National Meeting of Pneumology :https://fr.scribd.com/doc/96386408/prog-umpt-2012Google Scholar
  12. 12.
    Khelafi R, Aissanou A, Tarsift S, Skander F (2011) Epidemiology of chronic obstructive pulmonary disease in Algiers. Rev Mal Respir 28:32–40. doi:10.1016/j.rmr.2010.06.026
  13. 13.
  14. 14.
    AIDS in Algeria :http://www.unaids.org/en/regionscountries/countries/algeriaGoogle Scholar
  15. 15.
  16. 16.
    Renal transplant : www.algerie-focus.com/
  17. 17.
    Polatli M, Ben Kheder A, Wali S, Javed A, Khattab A, Mahboub B, Iraqi G, Nejjari C, Taright S, Koniski ML, Rashid N, El Hasnaoui A (2012) BREATHE Study Group. Chronic obstructive pulmonary disease and associated healthcare resource consumption in the Middle East and North Africa: the BREATHE study. Respir Med 106:S75–S85. doi:10.1016/S0954-6111(12)70016-1
  18. 18.
  19. 19.
    Djeridane A, Djeridane Y, Ammar-Khodja A (2006) Epidemiological and aetiological study on tineapedis and onychomycosis in Algeria. Mycoses 49:190–196Google Scholar
  20. 20.
    Benmezdad A, Moulahem T, Benyezzar M, Djaballah M, Beldjoudi W, Fendri AH (2012) Tinea capitis in the university hospital in Constantine (Algeria). J Mycol Med 22:354–356. doi:10.1016/j.mycmed.2012.09.002
  21. 21.
    Ilham A, Touabti A (2012) Les onychomycoses au laboratoire de parasitologie CHU Sétif : étude sur dix ans. J Mycol Med 81-82. doi:10.1016/j.mycmed.2012.12.036
  22. 22.
    Bendjaballah-Laliam A, Djazer H (2011) Teignes du cuir chevelu à l’ouest d’Alger (Wilaya de Tipasa) (2012). J Mycol Med 23:81. doi:10.1016/j.mycmed.2012.12.035
  23. 23.
    Chelgham I, Belkhelfa S, Achachi S, Aissaoui I, Mohamdi N (2011) Les mycoses superficielles: à propos des cas diagnostiques dans la région des Aures (Batna)/ Algérie de 2002 à 2011. J Mycol Med 22:113. doi:10.1016/j.mycmed.2011.12.045
  24. 24.
    Chekiri-Talbi, Denning D (2015) Etiological profile and epidemiology of tineacapitis in the region of Metidja (Blida) in Algeria. http://life-worldwide.org
  25. 25.
    Benmezdad A, Moulahem T Profil fongique des mycoses superficielles diagnostiquées au laboratoire de parasitologie–mycologie du CHU de Constantine : Étude rétrospective : années 2011–2012–2013. J Mycol Med 25:243. doi:10.1016/j.mycmed.2015.06.063
  26. 26.
    Oudainaa W, Biougnacha H, Rianea S, El Yaagoubila I, Tangia R, Ajdaea L, Agoumib A, Tliguib H (2011) Epidemiology of tineacapitis in outpatients at the Children’s Hospital in Rabat (Morocco). J Mycol Med 21:1–5. doi:10.1016/j.mycmed.2010.11.001
  27. 27.
    Bendjaballah-Laliam A, Djazer H (2014) Epidemiologie des teignes du cuir chevelu de la banlieue de Tipasa, Algerie. J Mycol Med 24:141–143. doi:10.1016/j.mycmed.2014.02.008
  28. 28.
    Neji S, Chakroun M, Dammak Y, Trabelsi H, Makni F, Cheikhrouhou F, Sellami H, Marrekchi S, Meziou J, Ayadi A (2012) Les mycoses superficielles : profil épidémiologique et mycologique des différents champignons isolés au CHU de Sfax (Tunisie). J Mycol Med 22:103–104. doi:10.1016/j.mycmed.2011.12.019
  29. 29.
    Achachi S, Chelgham I, Belkhelfa S, Aissaoui I, Mohamdi N (2011) Teigne favique chez une adulte. J Mycol Med 22:113–114. doi:10.1016/j.mycmed.2011.12.046
  30. 30.
    Haine-Madani K, Boukerzaza I, Hamrioui B (2013) Les otomycoses : épidémiologie et diagnostic au CHU Mustapha Bacha d’Alger. J Mycol Med 23:210. doi:10.1016/j.mycmed.2014.02.008
  31. 31.
    Merad Y, Adjmi-Hamoudi H, Lansari T, Cassaing S (2016) Les otomycosesdermatophytiques: étude rétrospective de 2010 à 2015. J Mycol Med 26:e35–e36. doi:10.1016/j.mycmed.2016.04.078
  32. 32.
    Merad Y, Adjmi-Hamoudi H, Lahmer K, Saadaoui E, Cassaing S, Berry A (2016) Les otomycoses chez les porteurs d’aides auditives: Etude rétrospective de 2010 à 2015. J Mycol Med 26:71. doi:10.1016/j.mycmed.2016.02.012
  33. 33.
    Foxman B, Muraglia R, Dietz JP, Sobel JD, Wagner J (2013) Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis 17:340–345Google Scholar
  34. 34.
    Ryan-Wenger NA, Neal JL, Jones AS, Lowe NK (2010) Accuracy of vaginal symptom self-diagnosis algorithms for deployed military women. Nurs Res 59:2–10. doi:10.1097/NNR.0b013e3181c3b9dd
  35. 35.
    Benaissaa S, Mehri N, Mansouri R, Bouchene Z (2011) Les mycoses oculaires et périoculaires, conduite diagnostique et thérapeutique, à propos de quelques cas. J Mycol Med 22:112. doi:10.1016/j.mycmed.2011.12.041
  36. 36.
    Zaki SM, Denning DW (2016) The burden of serious fungal deseases in Egypt. http://life-worldwide.org/assets/uploads/files/Egypt.pdf
  37. 37.
    Hadrich I, Makni F, Sellami H, Cheikhrouhou F, Sellami A, Bouaziz H, Hdiji S, Elloumi M, Ayadi A (2010) Invasive aspergillosis: epidemiology and environmental study in haematology patients (Sfax, Tunisia). Mycoses 53:443–447. doi:10.1111/j.1439-0507.2009.01710.x
  38. 38.
    Saghrouni F, Ben Youssef Y, Gheitha, Bouabidc Z, Ben Abdeljelila J, Khammaria I, Fathallaha A, Khlifb A, Ben Saïda M (2011) Twenty-nine cases of invasive aspergillosis in neutropenic patients. J Mycol Med 41:657–662. doi:10.1016/j.medmal.2011.09.011
  39. 39.
    Bouakba A (2012) La prévalence en Algérie de la BPCO estimée à près de 4% Moins de 10% des traitements utilisés sont conformes aux directives thérapeutiques actuelles http://www.vitaminedz.org/la-prevalence-en-algerie-de-la-bpco-estimee-a-pres-de-4/Articles_18300_796354_16_1.html
  40. 40.
    Yan X, Li M, Jiang M, Zou L, Luo F, Jiang Y (2009) Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: retrospective analysis of 1711 lung cancer cases. Cancer 115:5018–5025Google Scholar
  41. 41.
    Guinea J, Torres-Narbona M, Gijon P, Munoz P, Pozo F, Pelaez T et al (2010) Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 16:870–877Google Scholar
  42. 42.
    National survey on the cancer in Algeria. http://www.sante.dz/cancer/plan_national_cancer.pdf
  43. 43.
    Zait H, Arrache D, Madani K, Bentaiba K, Beradi K, Achir I, Bouhellal H, Matougui S, Amrane A, Zerouali H, Hamrioui B (2016) Vingt-quatre cas de cryptococcose diagnostiqués au laboratoire de parasitologie-mycologie du CHU Mustapha d’Alger 2002—2015. J Mycol Med 25:237. doi:10.1016/j.mycmed.2015.06.048
  44. 44.
    Tattevin P (2012) Cinquièmes Journées internationales d’infectiologie de Sétif Algérie (2012). La Lettre de l’Infectiologue XXVII:4Google Scholar
  45. 45.
    Lowe DM, Rangaka MX, Gordon F, James CD, Miller RF (2013) Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression. PLoS One 8(8), e69969Google Scholar
  46. 46.
    Seddiki SML, Boucherit-Otmania Z, Boucherit K, Kunkel D Fungal infectivities of implanted catheters due to Candida sp. Biofilms formation and resistance. J Mycol Med 25:130–135. doi:10.1016/j.mycmed.2015.03.003
  47. 47.
    Seghir A, Boucherit-Otmania Z, Belkherroubi-Saria L, Boucherit K (2014) Catheterization and fungal infection risk in the University Hospital of Tlemcen: epidemiology and susceptibility to antifungals. J Mycol Med 24:e179–e184. doi:10.1016/j.mycmed.2014.08.005
  48. 48.
    Vergidis P, Clancy CJ, Shields RK, Park SY, Wildfeuer BN, Simmons RL, Nguyen MH (2016) Intra-abdominal candidiasis: the importance of early source control and antifungal treatment. PLoS One 11, e0153247. doi:10.1371/journal.pone.0153247
  49. 49.
    Montravers P, Mira JP, Gangneux JP, Leroy O, Lortholary O (2011) A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive‐care units. Clin Microbiol Infect 17(7):1061–1067Google Scholar
  50. 50.
    Zait H, Hamrioui B (2011) Pulmonary aspergilloma: about 39 cases. J Mycol Med 21:138–141Google Scholar
  51. 51.
    Un million d’asthmatiques recensés en Algérie. Article in Algerian newspaper: 15 February 2014.http://www.radioalgerie.dz/news/fr/article/20150425/38291.html

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  1. 1.Pharmacy DepartmentUniversité Saad Dahlab de BlidaBlidaAlgeria
  2. 2.The University of Manchester, National Aspergillosis Centre, University Hospital of South Manchester and Manchester Academic Health Science CentreManchesterUK

Personalised recommendations